Partnership Opportunities
Together We’ll Achieve More
We’re Bringing RNA Fragmentomics to the World.
And we hope you’ll join us.
Our RiboMarker® RNA fragmentomics platform unlocks a new world of data-rich biomarkers that offer the opportunity to generate greater levels of insight into the transcriptome than ever before. We’re actively seeking industry and research collaborations to advance the discovery of novel RNA biomarkers and correlate them with clinical outcomes and genetic traits.
The scientists, inventors, and visionaries at RealSeq are eager to hear your ideas and discuss research and co-development opportunities. By bringing next-generation RNA-based diagnostics to fruition, we’ll improve countless lives for years to come.
Where We Can Work Together
Oncology
Leveraging our RiboMarker platform to unlock the dynamic biological data in RNA fragments, routine liquid biopsies can provide deeper oncology insights than ever before. Earlier detection, clearer visibility into progression, and more accurate analysis of treatment responses improve patient outcomes.
Infectious Disease
We’re constantly broadening our RiboMarker platform to address more diseases caused by fungi, viruses, bacteria, or parasites. Our inaugural diagnostic for the Valley Fever fungal disease is demonstrating the potential for RNA biomarkers to revolutionize the detection and treatment of infectious disease.
Agricultural Biotechnology
We are interested in AgBio collaborations that utilize the RiboMarker platform for plant and animal genetics, and advanced soil analysis. Our technology can assess the health and composition of samples, and detect a wide range of microbial RNA fragments to provide a detailed profile of soil microbiota.
